<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03347825</url>
  </required_header>
  <id_info>
    <org_study_id>ISI-dVLob-001</org_study_id>
    <nct_id>NCT03347825</nct_id>
  </id_info>
  <brief_title>Retrospective Multi-Center Study to Compare Perioperative Outcomes for Robotic-assisted Lobectomy With Those Associated With VATS and Open Lobectomy for Lung Cancer</brief_title>
  <acronym>PORTaL</acronym>
  <official_title>A Retrospective Multi-Center Study for Evaluation of Clinical Outcomes With Lobectomy for Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Intuitive Surgical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Intuitive Surgical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to evaluate and compare peri-operative outcomes of&#xD;
      lobectomy compare with different approaches. The study aims to include patients with stage&#xD;
      IA, IB, IIA, IIB and IIIA lung cancer that underwent lobectomy via robotic-assisted, VATS and&#xD;
      open approach.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center, retrospective chart review study of all consecutive lobectomies&#xD;
      performed for clinical stage IA, IB, IIA, IIB and IIIA lung cancer, performed by&#xD;
      participating surgeons at their respective institutions that meet all inclusion and exclusion&#xD;
      criteria. All cases of lobectomy performed for clinical stages, IA, IB, IIA, IIB and IIIA&#xD;
      lung cancer via robotic-assisted, VATS (video assisted thoracic surgery) and open approach&#xD;
      that meet the study inclusion and exclusion criteria will be considered for inclusion in the&#xD;
      study. The chart review and data collection will be performed in a reverse chronological&#xD;
      order starting at 30 days prior to IRB approval of the study at the institution and going&#xD;
      back to 2013 (i.e most current data in 2017 and chronologically going back through 2013). The&#xD;
      retrospective chart review and data collection is anticipated to occur in two phases:&#xD;
&#xD;
      Baseline patient characteristics, perioperative and post-operative short term clinical and&#xD;
      pathological outcomes data will be obtained from hospital records. Each participating&#xD;
      institution will contribute approximately 100-800 cases from one or more surgeons. Since the&#xD;
      data will have been de-identified, and is archival in nature, there will be no active subject&#xD;
      recruitment and no patient consenting is required&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Actual">July 1, 2020</completion_date>
  <primary_completion_date type="Actual">July 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Chart review and data collection of clinical stage IB, IIA, IIB, IIIA cases</measure>
    <time_frame>2013-2019</time_frame>
    <description>Compare peri-operative outcomes of robotic-assisted lobectomy with those associated with VATS and open lobectomy for lung cancer</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">7000</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Robotic-assisted lobectomy</arm_group_label>
    <description>Pre-operative, intra-operative and post-operative clinical, surgical and oncological information will be obtained from institutional records for patients who underwent robotic-assisted lobectomy for lung cancer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VATS (video assisted thoracic surgery) lobectomy</arm_group_label>
    <description>Pre-operative, intra-operative and post-operative clinical, surgical and oncological information will be obtained from institutional records for patients who underwent VATS lobectomy for lung cancer.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Open lobectomy</arm_group_label>
    <description>Pre-operative, intra-operative and post-operative clinical, surgical and oncological information will be obtained from institutional records for patients who underwent open lobectomy for lung cancer.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Robotic-assisted lobectomy using da Vinci Surgical System</intervention_name>
    <description>Robotic-assisted lobectomy</description>
    <arm_group_label>Robotic-assisted lobectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>VATS (video assisted thoracic surgery)</intervention_name>
    <description>VATS (video assisted thoracic surgery)</description>
    <arm_group_label>VATS (video assisted thoracic surgery) lobectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open lobectomy</intervention_name>
    <description>Open lobectomy</description>
    <arm_group_label>Open lobectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who underwent robotic-assisted, VATS or open lobectomy for primary stage IA, IB,&#xD;
        IIA, IIB and IIIA lung cancer, with or without neo-adjuvant therapy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Subject is 18 years or older&#xD;
&#xD;
          -  Subject who has undergone elective robotic-assisted, VATS or open lobectomy for&#xD;
             clinically diagnosed primary stage IA, IB, IIA, IIB and IIIA lung cancer, with or&#xD;
             without neo-adjuvant therapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Subject with stage IIIB lung cancer&#xD;
&#xD;
          -  Subject who received lobectomy as an emergent procedure&#xD;
&#xD;
          -  Subjects who received lobectomy for metastatic cancer&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>BaylorScott&amp;White</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>October 31, 2017</study_first_submitted>
  <study_first_submitted_qc>November 15, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 20, 2017</study_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

